I left last weeks Rose Cafe presentation and discussion led by the GRF Shiv with the understanding that organoids are essentially mini organs engineered in vitro. These can be used to develop and test treatments and therapies including those for some of the most pressing current health problems such as different types of cancer and addiction. While this discussion was interesting, after the discussion I was still curious and interested in broader ethical implications of this biotechnology: would organoid use for developing new treatments or more efficiently produce existing treatments raise the cost of these drugs or lower cost? What are some potential consequences or externalities, either positive or negative of this technology? I also appreciated that the speaker spoke a bit about his academic/ career trajectory and motivation for pursuing engineering graduate studies here before going to med school.